These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 6543129)
21. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
22. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats. Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of radiolabelled quinlukast in rats. Syrovatko M; Laznickova A; Laznicek M J Pharm Biomed Anal; 2005 Jun; 38(2):313-9. PubMed ID: 15925224 [TBL] [Abstract][Full Text] [Related]
24. [Biotransformation and pharmacokinetics of beta-methyl-(1,1'-biphenyl)-4-propanenitrile (LU 20884) in rats. Studies on pharmacokinetics]. Neidlein R; Hofmann G Arzneimittelforschung; 1983; 33(8):1152-5. PubMed ID: 6685492 [TBL] [Abstract][Full Text] [Related]
25. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats. Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats. DuchĂȘne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and metabolism of the prodrug DB289 (2,5-bis[4-(N-methoxyamidino)phenyl]furan monomaleate) in rat and monkey and its conversion to the antiprotozoal/antifungal drug DB75 (2,5-bis(4-guanylphenyl)furan dihydrochloride). Midgley I; Fitzpatrick K; Taylor LM; Houchen TL; Henderson SJ; Wright SJ; Cybulski ZR; John BA; McBurney A; Boykin DW; Trendler KL Drug Metab Dispos; 2007 Jun; 35(6):955-67. PubMed ID: 17360833 [TBL] [Abstract][Full Text] [Related]
28. Single-dose pharmacokinetics of the trypanosomicide benznidazole in man. Raaflaub J; Ziegler WH Arzneimittelforschung; 1979; 29(10):1611-4. PubMed ID: 583230 [TBL] [Abstract][Full Text] [Related]
29. Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). Zhou S; Kestell P; Tingle MD; Paxton JW Cancer Chemother Pharmacol; 2002 Feb; 49(2):126-32. PubMed ID: 11862426 [TBL] [Abstract][Full Text] [Related]
30. Metabolism, disposition, excretion, and pharmacokinetics of levormeloxifene, a selective estrogen receptor modulator, in the rat. Mountfield RJ; Kiehr B; John BA Drug Metab Dispos; 2000 May; 28(5):503-13. PubMed ID: 10772628 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice. Noker PE; Hill DL; Kalin JR; Temple CG; Montgomery JA Drug Metab Dispos; 1985; 13(6):677-81. PubMed ID: 2867870 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics, biliary excretion, and tissue distribution of novel anti-HIV agents, cosalane and dihydrocosalane, in Sprague-Dawley rats. Kuchimanchi KR; Udata C; Johnston TP; Mitra AK Drug Metab Dispos; 2000 Apr; 28(4):403-8. PubMed ID: 10725308 [TBL] [Abstract][Full Text] [Related]
33. Disposition and metabolism of some nitrofurylthiazoles possessing antiparasitic activity. Chatfield DH Xenobiotica; 1976 Aug; 6(8):509-20. PubMed ID: 983121 [TBL] [Abstract][Full Text] [Related]
34. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys. Emary WB; Toren PC; Mathews B; Huh K Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats. Paulson SK; Zhang JY; Breau AP; Hribar JD; Liu NW; Jessen SM; Lawal YM; Cogburn JN; Gresk CJ; Markos CS; Maziasz TJ; Schoenhard GL; Burton EG Drug Metab Dispos; 2000 May; 28(5):514-21. PubMed ID: 10772629 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the metabolism and pharmacokinetics of metbufen and itanoxone and their analogues in rats. Chanal JL; Audran M; Bret MC; Cousse H; Fauran F; Rieu JP Arzneimittelforschung; 1988 Oct; 38(10):1454-60. PubMed ID: 3196384 [TBL] [Abstract][Full Text] [Related]
37. MR 714, a new aryloxypropionic non-steroidal antiinflammatory agent. Chemical and pharmacokinetic properties and preliminary pharmacotoxicological data. Marzo A; Quadro G; Bruno G; Treffner E; Reali FL; Borrelli G; Stradi R Arzneimittelforschung; 1983; 33(2):198-205. PubMed ID: 6342626 [TBL] [Abstract][Full Text] [Related]
38. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
39. Disposition of remoxipride in different species. Species differences in metabolism. Widman M; Nilsson LB; Bryske B; Lundström J Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice. Smith NF; Hayes A; Nutley BP; Raynaud FI; Workman P Cancer Chemother Pharmacol; 2004 Dec; 54(6):475-86. PubMed ID: 15526201 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]